Recombinant human fibroblast growth factors offer growth prospects in regenerative medicine and cosmetics, driven by efficient production systems. Key opportunities arise from applications in wound ...
The fibroblast growth factor market presents opportunities in regenerative medicine, oncology, and metabolic disorders due to advances in molecular biology and delivery technologies. Key opportunities ...
FGF2 offers strategic growth opportunities in regenerative medicine and biopharmaceuticals, driven by advances in expression technologies and innovative delivery systems. Collaborative frameworks and ...
Chemical and biotech company WACKER has announced the launch of a new bioengineered growth factor specially developed for use ...
Researchers at Texas A&M University have uncovered a key element of joint cartilage regrowth, which brings them one step ...
CompletedstrategicpivotfromR&Dfocustocommercial focusRebranded as Dyadic Applied BioSolutions and launched redesigned website ...
Completed strategic pivot from R&D focus to commercial focusRebranded as Dyadic Applied BioSolutions and launched redesigned website to optimize commercial engagement and investor relationsAdvanced mu ...
Scientists said on Monday they had taken a first step towards being able to control stem cells -- master cells that have the ability to become any kind of cell in the body. Doctors hope one day these ...
A hormone known for regulating energy balance also helps the body cope with influenza by triggering protective responses in ...
Tyra Biosciences, Inc. , a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) ...
Tyra Biosciences, Inc. , a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) ...
The drug, given as a weekly subcutaneous injection, reduced both triglycerides and liver fat in the phase II trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback